C260-3422 Screening compound: 1-{[(3,4-dimethylphenyl)carbamoyl]methyl}-N-[(furan-2-yl)methyl]-2,4-dioxo-3-phenyl-1,2,3,4-tetrahydroquinazoline-7-carboxamide

C260-3422 Screening compound: 1-{[(3,4-dimethylphenyl)carbamoyl]methyl}-N-[(furan-2-yl)methyl]-2,4-dioxo-3-phenyl-1,2,3,4-tetrahydroquinazoline-7-carboxamide
C260-3422 Screening compound: 1-{[(3,4-dimethylphenyl)carbamoyl]methyl}-N-[(furan-2-yl)methyl]-2,4-dioxo-3-phenyl-1,2,3,4-tetrahydroquinazoline-7-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C260-3422
1-{[(3,4-dimethylphenyl)carbamoyl]methyl}-N-[(furan-2-yl)methyl]-2,4-dioxo-3-phenyl-1,2,3,4-tetrahydroquinazoline-7-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C260-3422

Molecular Formula

C30H26N4O5 (C30 H26 N4 O5)

Compound Name

1-{[(3,4-dimethylphenyl)carbamoyl]methyl}-N-[(furan-2-yl)methyl]-2,4-dioxo-3-phenyl-1,2,3,4-tetrahydroquinazoline-7-carboxamide

IUPAC name

1-{[(34-dimethylphenyl)carbamoyl]methyl}-N-[(furan-2-yl)methyl]-24-dioxo-3-phenyl-1234-tetrahydroquinazoline-7-carboxamide

SMILES

Cc(cc1)c(C)cc1NC(CN(c(cc(cc1)C(NCc2ccco2)=O)c1C(N1c2ccccc2)=O)C1=O)=O

InChI

InChI=1S/C30H26N4O5/c1-19-10-12-22(15-20(19)2)32-27(35)18-33-26-16-21(28(36)31-17-24-9-6-14-39-24)11-13-25(26)29(37)34(30(33)38)23-7-4-3-5-8-23/h3-16H,17-18H2,1-2H3,(H,31,36)(H,32,35)

InChI Key

MPHZISJOCUIKKS-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14739160

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

522.56

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

4.460

Distribution Coefficient, logD

4.459

Water Solubility, LogSw

-4.31

Polar Surface Area

85.967

Acid Dissociation Constant (pKa)

12.06

Base Dissociation Constant (pKb)

2.38

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

13.30

C260-3422 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Purinergic Library (3321 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Cardiovascular
  • Metabolic
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • GPCR
  • Ion Channels
  • Phosphatases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with C260-3422 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C260-3422?
Check Price and Availability of C260-3422, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C260-3422 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C260-3422
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C260-3422
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C260-3422 available by request